HIV流行地区耐药结核病的传播
本文综述了HIV高负担地区耐多药结核病传播的现状与干预需求。HIV加速结核病进展,导致耐多药结核传播与耐药放大。需联合快速分子诊断、缩短传染期的化疗、感染控制及接触者主动筛查与预防性治疗。
要点
- HIV加速结核病进展,促进耐多药结核传播与耐药放大。
- HIV流行区需联合快速分子诊断与缩短传染期的化疗。
- 应实施感染控制及耐多药结核接触者主动筛查与预防性治疗。
核心结论
- HIV对结核病自然史有深刻影响,表现为疾病进展加快,导致耐多药结核传播增加和耐药放大。
- HIV流行地区亟需特异性干预措施阻断结核传播。
研究设计与样本
- 本文为系列文章中的综述,回顾HIV高负担地区耐多药结核传播的已知信息并定义研究优先方向。
主要发现
- 耐多药结核流行是耐药突变在不充分抗结核治疗中被选择的结果。
- HIV感染加速结核病进展,增加传播并放大耐多药结核。
临床怎么用
- 干预应包括快速分子诊断与改进化疗以缩短传染期。
- 实施感染控制措施,并对耐多药结核接触者主动筛查。
- 对无疾病证据的个体给予预防性治疗方案。
局限性
- 需更深入理解HIV流行地区影响耐多药结核传播的因素,包括基于人群的分子流行病学研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The emergence and expansion of the multidrug-resistant tuberculosis epidemic is a threat to the global control of tuberculosis. Multidrug-resistant tuberculosis is the result of the selection of resistance-conferring mutations during inadequate antituberculosis treatment. However, HIV has a profound effect on the natural history of tuberculosis, manifesting in an increased rate of disease progression, leading to increased transmission and amplification of multidrug-resistant tuberculosis. Interventions specific to HIV-endemic areas are urgently needed to block tuberculosis transmission. These interventions should include a combination of rapid molecular diagnostics and improved chemotherapy to shorten the duration of infectiousness, implementation of infection control measures, and active screening of multidrug-resistant tuberculosis contacts, with prophylactic regimens for individuals without evidence of disease. Development and improvement of the efficacy of interventions will require a greater understanding of the factors affecting the transmission of multidrug-resistant tuberculosis in HIV-endemic settings, including population-based molecular epidemiology studies. In this Series article, we review what we know about the transmission of multidrug-resistant tuberculosis in settings with high burdens of HIV and define the research priorities required to develop more effective interventions, to diminish ongoing transmission and the amplification of drug resistance.
引用
- Khan PY, Yates TA, Osman M, et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2018. PMID: 30554996. doi:10.1016/S1473-3099(18)30537-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。